265 related articles for article (PubMed ID: 35243876)
1. Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation.
Lin SY; Chang YC; Lin FJ; Tang SC; Dong YH; Wang CC
J Am Heart Assoc; 2022 Mar; 11(6):e022849. PubMed ID: 35243876
[TBL] [Abstract][Full Text] [Related]
2. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
3. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
[TBL] [Abstract][Full Text] [Related]
4. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
[TBL] [Abstract][Full Text] [Related]
5. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.
Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GYH; Larsen TB
Stroke; 2019 Apr; 50(4):939-946. PubMed ID: 30869568
[TBL] [Abstract][Full Text] [Related]
6. Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage.
Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
Stroke; 2020 Feb; 51(2):416-423. PubMed ID: 31813363
[TBL] [Abstract][Full Text] [Related]
7. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
8. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage.
Chao TF; Liu CJ; Liao JN; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Lip GY; Chen SA
Circulation; 2016 Apr; 133(16):1540-7. PubMed ID: 26969761
[TBL] [Abstract][Full Text] [Related]
9. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry.
Shiozawa M; Koga M; Inoue H; Yamashita T; Yasaka M; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Nakahara J; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T; Toyoda K
Int J Stroke; 2023 Oct; 18(8):986-995. PubMed ID: 37154598
[TBL] [Abstract][Full Text] [Related]
10. The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study.
Tsai CT; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA; Chao TF
BMC Med; 2024 Mar; 22(1):113. PubMed ID: 38475752
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy).
Poli L; Grassi M; Zedde M; Marcheselli S; Silvestrelli G; Sessa M; Zini A; Paciaroni M; Azzini C; Gamba M; Toriello A; Tassi R; Giorli E; Calabrò RS; Ritelli M; De Vito A; Pugliese N; Martini G; Lanari A; Lodigiani C; Padroni M; De Giuli V; Caria F; Morotti A; Costa P; Strambo D; Corato M; Pascarella R; Del Sette M; Malferrari G; Colombi M; Padovani A; Pezzini A;
Thromb Haemost; 2018 Mar; 118(3):572-580. PubMed ID: 29433151
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis.
Ivany E; Ritchie LA; Lip GYH; Lotto RR; Werring DJ; Lane DA
Stroke; 2022 Oct; 53(10):3035-3046. PubMed ID: 35862238
[TBL] [Abstract][Full Text] [Related]
13. Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries.
Lim TW; Camm AJ; Virdone S; Singer DE; Bassand JP; Fonarow GC; Fox KAA; Ezekowitz M; Gersh BJ; Kayani G; Hylek EM; Kakkar AK; Mahaffey KW; Pieper KS; Peterson ED; Piccini JP;
Clin Cardiol; 2023 Nov; 46(11):1398-1407. PubMed ID: 37596725
[TBL] [Abstract][Full Text] [Related]
14. Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation.
Graham DJ; Baro E; Zhang R; Liao J; Wernecke M; Reichman ME; Hu M; Illoh O; Wei Y; Goulding MR; Chillarige Y; Southworth MR; MaCurdy TE; Kelman JA
Am J Med; 2019 May; 132(5):596-604.e11. PubMed ID: 30639551
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation.
Chao TF; Chiang CE; Chan YH; Liao JN; Chen TJ; Lip GYH; Chen SA
Heart Rhythm; 2021 Jun; 18(6):871-877. PubMed ID: 33640447
[TBL] [Abstract][Full Text] [Related]
16. Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
Gulati S; Solheim O; Carlsen SM; Øie LR; Jensberg H; Gulati AM; Madsbu MA; Giannadakis C; Jakola AS; Salvesen Ø
PLoS One; 2018; 13(8):e0202575. PubMed ID: 30138389
[TBL] [Abstract][Full Text] [Related]
17. Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study.
Forslund T; Wettermark B; Andersen M; Hjemdahl P
Europace; 2018 Mar; 20(3):420-428. PubMed ID: 28177459
[TBL] [Abstract][Full Text] [Related]
18. Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage.
Wu VC; Huang YC; Chen SW; Liu CH; Chang CW; Chen CC; Chang SH; Lin MS; Lee TH; Chen MC; Hsieh IC; Chu PH; Lin YS
Medicine (Baltimore); 2021 Aug; 100(32):e26945. PubMed ID: 34397946
[TBL] [Abstract][Full Text] [Related]
19. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy for stroke prevention in patients with atrial fibrillation who survive an intracerebral haemorrhage: results of an EHRA survey.
Ivany E; Lane DA; Dan GA; Doehner W; Farkowski MM; Iliodromitis K; Lenarczyk R; Potpara TS
Europace; 2021 May; 23(5):806-814. PubMed ID: 34020460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
